In a phase 1 trial, a new vaccine candidate against Lassa fever demonstrates an acceptable safety profile and induces strong, long-lasting immune responses.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lassa-fever-vaccine-shows-encouraging-results-phase-1-2025a10010j3?src=rss
Author :
Publish date : 2025-12-29 10:40:00
Copyright for syndicated content belongs to the linked Source.
